旗濱集團(601636.SH):擬將旗濱電子分拆至深交所創業板上市
格隆匯10月18日丨旗濱集團(601636.SH)公佈,旗濱集團擬將其控股子公司旗濱電子分拆至深交所創業板上市。此次分拆上市完成後,旗濱集團股權結構不會發生變化,且仍將維持對旗濱電子的控制權。
通過此次分拆上市,可使得旗濱集團和旗濱電子的主業結構更加清晰。旗濱集團將進一步實現業務聚焦,專注於浮法玻璃原片、節能建築玻璃、光伏玻璃及藥用玻璃的生產、銷售,將旗濱電子打造成公司下屬電子玻璃業務的獨立上市平台,通過創業板上市進一步加大旗濱電子核心技術的投入,實現高性能電子玻璃業務板塊的進一步做大做強。此次分拆有利於提升上市公司整體價值,增強公司及所屬子公司的盈利能力和綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.